Biopharmaceutical benchmarks 2014

Nat Biotechnol. 2014 Oct;32(10):992-1000. doi: 10.1038/nbt.3040.
No abstract available

MeSH terms

  • Animals
  • Antibodies, Monoclonal*
  • Biomedical Research
  • Biopharmaceutics
  • Biosimilar Pharmaceuticals*
  • Biotechnology* / organization & administration
  • Biotechnology* / trends
  • Drug Approval
  • Drug Industry* / organization & administration
  • Drug Industry* / trends
  • Europe
  • Genetic Therapy
  • Humans
  • Mice
  • United States

Substances

  • Antibodies, Monoclonal
  • Biosimilar Pharmaceuticals